ZP3

gene
On this page

Also known as ZP3-424ZP3-372ZPC

Summary

ZP3 (zona pellucida glycoprotein 3, HGNC:13189) is a protein-coding gene on chromosome 7q11.23, encoding Zona pellucida sperm-binding protein 3 (P21754). Component of the zona pellucida, an extracellular matrix surrounding oocytes which mediates sperm binding, induction of the acrosome reaction and prevents post-fertilization polyspermy.

The zona pellucida is an extracellular matrix that surrounds the oocyte and early embryo. It is composed primarily of three or four glycoproteins with various functions during fertilization and preimplantation development. The protein encoded by this gene is a structural component of the zona pellucida and functions in primary binding and induction of the sperm acrosome reaction. The nascent protein contains a N-terminal signal peptide sequence, a conserved ZP domain, a C-terminal consensus furin cleavage site, and a transmembrane domain. It is hypothesized that furin cleavage results in release of the mature protein from the plasma membrane for subsequent incorporation into the zona pellucida matrix. However, the requirement for furin cleavage in this process remains controversial based on mouse studies. A variation in the last exon of this gene has previously served as the basis for an additional ZP3 locus; however, sequence and literature review reveals that there is only one full-length ZP3 locus in the human genome. Another locus encoding a bipartite transcript designated POMZP3 contains a duplication of the last four exons of ZP3, including the above described variation, and maps closely to this gene.

Source: NCBI Gene 7784 — RefSeq curated summary.

At a glance

  • Gene–disease (curated): oocyte maturation defect 3 (Strong, GenCC) — +2 more curated relationships
  • GWAS associations: 1
  • Clinical variants (ClinVar): 122 total — 4 pathogenic, 1 likely-pathogenic
  • Phenotypes (HPO): 3
  • MANE Select transcript: NM_001110354

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:13189
Approved symbolZP3
Namezona pellucida glycoprotein 3
Location7q11.23
Locus typegene with protein product
StatusApproved
AliasesZP3-424, ZP3-372, ZPC
Ensembl geneENSG00000188372
Ensembl biotypeprotein_coding
OMIM182889
Entrez7784

Gene structure

Transcript identifiers

Ensembl transcripts: 7 — 4 protein_coding, 2 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000336517, ENST00000394857, ENST00000394860, ENST00000416245, ENST00000466960, ENST00000467555, ENST00000479793

RefSeq mRNA: 2 — MANE Select: NM_001110354 NM_001110354, NM_007155

CCDS: CCDS47618, CCDS5586

Canonical transcript exons

ENST00000394857 — 8 exons

ExonStartEnd
ENSE000009188207642951576429633
ENSE000009188227643347076433647
ENSE000015198247642495076425276
ENSE000025231867643403876434155
ENSE000036423017644025076440341
ENSE000036680677643292776433030
ENSE000036684757644047576440611
ENSE000038503857644184276442069

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 89.00.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.8765 / max 74.8760, expressed in 971 samples.

FANTOM5 promoters (8 alternative TSS)

Promoter IDTPM avgSamples expressed
791682.2400765
791710.5660294
791670.3984222
791690.2246125
791700.1794100
791730.132865
791720.113750
791750.02147

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
lower esophagus mucosaUBERON:003583489.00gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099184.23gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047383.49gold quality
apex of heartUBERON:000209883.07gold quality
mucosa of transverse colonUBERON:000499182.35gold quality
bone marrow cellCL:000209280.09gold quality
ventricular zoneUBERON:000305379.03gold quality
muscle tissueUBERON:000238578.67gold quality
body of pancreasUBERON:000115078.62gold quality
right adrenal gland cortexUBERON:003582778.46gold quality
esophagus mucosaUBERON:000246978.30gold quality
nucleus accumbensUBERON:000188278.11gold quality
fundus of stomachUBERON:000116078.10gold quality
skeletal muscle tissueUBERON:000113477.98gold quality
mucosa of stomachUBERON:000119977.98gold quality
putamenUBERON:000187477.69gold quality
right uterine tubeUBERON:000130277.67gold quality
skin of legUBERON:000151177.36gold quality
zone of skinUBERON:000001477.15gold quality
right adrenal glandUBERON:000123376.88gold quality
left adrenal gland cortexUBERON:003582576.88gold quality
bloodUBERON:000017876.74gold quality
skin of abdomenUBERON:000141676.68gold quality
vaginaUBERON:000099676.67gold quality
corpus callosumUBERON:000233676.40gold quality
left adrenal glandUBERON:000123476.36gold quality
thoracic mammary glandUBERON:000520076.26gold quality
pancreasUBERON:000126476.21gold quality
left ovaryUBERON:000211976.19gold quality
ectocervixUBERON:001224976.09gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-MTAB-8381yes2069.79
E-GEOD-36552yes411.72
E-ANND-3no2.35

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): FIGLA, SOHLH1

Literature-anchored findings (GeneRIF, showing 26)

  • Eggs expressing glycoprotein huZP3, derived from transgenic mice, bind murine but not human sperm, implying that huZP3 acquires the same O-glycans as native mZP3. (PMID:14673092)
  • human and mouse ZP3 proteins are quite similar, and alternative explanations of taxon-specific sperm binding warrant exploration (PMID:15379548)
  • Binding sites for recombinant zona pellucida C (ZPC) glycoprotein are located both at the N- and C-terminus of proacrosin (PMID:15950651)
  • Exposure of sperm to ZP proteins promoted acrosomal exocytosis and changed motility patterns. (PMID:16407501)
  • Peptides rhuZP3a22 approximately 176 and rhuZP3b177 approximately 348 have a role similar to human ZP3. The mechanism of the response to the peptides involves influx of calcium, the G protein pathway, and a T-type calcium channel. (PMID:17192598)
  • ZP proteins were detected in both the oocyte and the granulosa cells as early as the primordial follicle stage in the human. The detection of ZP proteins in the quiescent primordial follicle suggests that these proteins have been present since oogenesis. (PMID:18033806)
  • may have a role in the development of primordial follicle before zona pellucida formation (PMID:18502569)
  • induces acrosome reactions which are protein kinase-C, protein tyrosine kinase, T-type Ca2+ channels, and extracellular Ca2+ dependent (PMID:18667750)
  • a significant decrease in acrosomal exocytosis mediated by both recombinant human ZP3 (p<0.005) and ZP4 (p<0.005) was observed in presence of the immune sera (PMID:19004505)
  • The functional activity of human ZP3 resides in its C-terminal domain. (PMID:19246320)
  • observed sequence variations in exons of ZP3 gene in women with infertility of unknown origin who exhibit abnormal zona pellucida; sperm-ovum interactions appear relatively normal in these patients [CASE REPORTS] (PMID:22889493)
  • Epididymal CRISP1 mediates sperm-zona pellucida binding through its interaction with ZP3. (PMID:24334245)
  • The oocyte ZP3 expression was the main predictor of the fertilization capacity. (PMID:28204536)
  • Mutations in ZP2 and ZP3 have dosage effects which can cause female infertility in humans. (PMID:28646452)
  • Missense Mutation in ZP3 gene is associated with Empty Follicle Syndrome and Female Infertility. (PMID:28886344)
  • The zona pellucida-3 (ZP3) protein plays a pivotal role in oocyte and gamete development. (PMID:30341457)
  • Mutations in ZP1, ZP2, and ZP3 might affect the corresponding protein expression, secretion, and interaction, thus providing a mechanistic explanation for the phenotypes for female infertility. (PMID:30810869)
  • Zona Pellucida Proteins, Fibrils, and Matrix. (PMID:32569527)
  • Heterozygous mutations in ZP1 and ZP3 cause formation disorder of ZP and female infertility in human. (PMID:32573113)
  • A novel mutation in ZP3 causes empty follicle syndrome and abnormal zona pellucida formation. (PMID:33140178)
  • A novel homozygous variant in ZP2 causes abnormal zona pellucida formation and female infertility. (PMID:33604805)
  • Novel expression of zona pellucida 3 protein in normal testis; potential functional implications. (PMID:34736966)
  • A novel gene mutation in ZP3 loop region identified in patients with empty follicle syndrome. (PMID:34816529)
  • Novel mutations in ZP2 and ZP3 cause female infertility in three patients. (PMID:35366744)
  • Novel mutations in TUBB8 and ZP3 cause human oocyte maturation arrest and female infertility. (PMID:36335766)
  • Novel variants in ZP1, ZP2 and ZP3 associated with empty follicle syndrome and abnormal zona pellucida. (PMID:36931917)

Cross-species orthologs

9 orthologs

OrganismSymbolGene ID
danio_reriozp3eENSDARG00000016908
danio_reriozp3bENSDARG00000039828
danio_reriozp3a.1ENSDARG00000042129
danio_reriozp3a.2ENSDARG00000042130
danio_reriozp3.2ENSDARG00000090768
danio_reriozp3ENSDARG00000114958
danio_reriozp3.2ENSDARG00000115457
mus_musculusZp3ENSMUSG00000004948
rattus_norvegicusZp3ENSRNOG00000001434

Paralogs (1): POMZP3 (ENSG00000146707)

Protein

Protein identifiers

Zona pellucida sperm-binding protein 3P21754 (reviewed: P21754)

Alternative names: Sperm receptor, ZP3A/ZP3B, Zona pellucida glycoprotein 3, Zona pellucida protein C

All UniProt accessions (3): P21754, E9PFI9, H0Y3M4

UniProt curated annotations — full annotation on UniProt →

Function. Component of the zona pellucida, an extracellular matrix surrounding oocytes which mediates sperm binding, induction of the acrosome reaction and prevents post-fertilization polyspermy. The zona pellucida is composed of 3 to 4 glycoproteins, ZP1, ZP2, ZP3, and ZP4. ZP3 is essential for sperm binding and zona matrix formation.

Subunit / interactions. Polymers of ZP2 and ZP3 organized into long filaments cross-linked by ZP1 homodimers. Interacts with ZP1 and ZP2.

Subcellular location. Zona pellucida Cell membrane.

Tissue specificity. Expressed in oocytes (at protein level).

Post-translational modifications. Proteolytically cleaved before the transmembrane segment to yield the secreted ectodomain incorporated in the zona pellucida. N-glycosylated. O-glycosylated; removal of O-linked glycans may play an important role in the post-fertilization block to polyspermy.

Disease relevance. Oocyte/zygote/embryo maturation arrest 3 (OZEMA3) [MIM:617712] An autosomal dominant infertility disorder characterized by abnormal oocytes that lack the zona pellucida, and oocytes degeneration. The disease is caused by variants affecting the gene represented in this entry.

Domain organisation. The ZP domain is involved in the polymerization of the ZP proteins to form the zona pellucida.

Miscellaneous. Found in a second polymorphic locus which, due to an extra G residue in exon 8, has the potential to encode a truncated protein of 372 amino acids.

Similarity. Belongs to the ZP domain family. ZPC subfamily.

Isoforms (3)

UniProt IDNamesCanonical?
P21754-1ZP3Ayes
P21754-2ZP3B
P21754-33

RefSeq proteins (2): NP_001103824, NP_009086 (=MANE)

Domains & families (InterPro)

IDNameType
IPR001507ZP_domDomain
IPR017977ZP_dom_CSConserved_site
IPR042235ZP-C_domHomologous_superfamily
IPR048290ZP_chrDomain
IPR055355ZP-CDomain
IPR055356ZP-NDomain

Pfam: PF00100, PF23344

UniProt features (28 total): glycosylation site 6, disulfide bond 4, sequence variant 4, splice variant 3, chain 2, topological domain 2, signal peptide 1, sequence conflict 1, propeptide 1, transmembrane region 1, domain 1, region of interest 1, modified residue 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P21754-F177.320.52

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 23

Disulfide bonds (4): 46–140, 78–99, 217–282, 239–300

Glycosylation sites (6): 125, 147, 156, 162, 163, 272

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-2534343Interaction With Cumulus Cells And The Zona Pellucida

MSigDB gene sets: 234 (showing top): GOBP_REGULATION_OF_CELL_ACTIVATION, GOBP_SINGLE_FERTILIZATION, GOBP_NEGATIVE_REGULATION_OF_REPRODUCTIVE_PROCESS, GOBP_REGULATION_OF_LEUKOCYTE_PROLIFERATION, GOBP_POSITIVE_REGULATION_OF_REPRODUCTIVE_PROCESS, GOBP_EMBRYO_DEVELOPMENT_ENDING_IN_BIRTH_OR_EGG_HATCHING, GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS, GOBP_POSITIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE, GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS, GOBP_INFLAMMATORY_RESPONSE, KAAB_FAILED_HEART_ATRIUM_DN, GOBP_REGULATION_OF_DEVELOPMENTAL_GROWTH, GOBP_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE, GOBP_GROWTH, GOBP_OOGENESIS

GO Biological Process (21): positive regulation of type IV hypersensitivity (GO:0001809), blastocyst formation (GO:0001825), humoral immune response mediated by circulating immunoglobulin (GO:0002455), positive regulation of leukocyte migration (GO:0002687), positive regulation of humoral immune response (GO:0002922), binding of sperm to zona pellucida (GO:0007339), positive regulation of type II interferon production (GO:0032729), positive regulation of interleukin-4 production (GO:0032753), egg coat formation (GO:0035803), positive regulation of T cell proliferation (GO:0042102), negative regulation of DNA-templated transcription (GO:0045892), positive regulation of DNA-templated transcription (GO:0045893), oocyte development (GO:0048599), positive regulation of inflammatory response (GO:0050729), positive regulation of acrosome reaction (GO:2000344), negative regulation of binding of sperm to zona pellucida (GO:2000360), positive regulation of acrosomal vesicle exocytosis (GO:2000368), positive regulation of ovarian follicle development (GO:2000386), positive regulation of antral ovarian follicle growth (GO:2000388), signal transduction (GO:0007165), single fertilization (GO:0007338)

GO Molecular Function (7): extracellular matrix structural constituent (GO:0005201), carbohydrate binding (GO:0030246), acrosin binding (GO:0032190), structural constituent of egg coat (GO:0035804), identical protein binding (GO:0042802), receptor ligand activity (GO:0048018), protein binding (GO:0005515)

GO Cellular Component (6): extracellular region (GO:0005576), obsolete extracellular space (GO:0005615), plasma membrane (GO:0005886), extracellular matrix (GO:0031012), egg coat (GO:0035805), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Fertilization1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
positive regulation of reproductive process3
humoral immune response2
positive regulation of cytokine production2
DNA-templated transcription2
regulation of DNA-templated transcription2
binding2
cellular anatomical structure2
type IV hypersensitivity1
regulation of type IV hypersensitivity1
positive regulation of T cell mediated immunity1
positive regulation of hypersensitivity1
blastocyst development1
anatomical structure formation involved in morphogenesis1
immunoglobulin mediated immune response1
positive regulation of immune system process1
regulation of leukocyte migration1
positive regulation of cell migration1
leukocyte migration1
regulation of humoral immune response1
positive regulation of immune response1
sperm-egg recognition1
type II interferon production1
regulation of type II interferon production1
interleukin-4 production1
regulation of interleukin-4 production1
cellular process involved in reproduction in multicellular organism1
oogenesis1
T cell proliferation1
regulation of T cell proliferation1
positive regulation of lymphocyte proliferation1
positive regulation of T cell activation1
negative regulation of RNA biosynthetic process1
positive regulation of RNA biosynthetic process1
germ cell development1
oocyte differentiation1
inflammatory response1
positive regulation of defense response1
positive regulation of response to external stimulus1
regulation of inflammatory response1
acrosome reaction1

Protein interactions and networks

STRING

758 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZP3ZP1P60852999
ZP3ZP4Q12836999
ZP3ZP2Q05996990
ZP3PKDREJQ9NTG1939
ZP3PLAC1Q9HBJ0885
ZP3GDF9O60383789
ZP3SNU13P55769763
ZP3ZANQ9Y493759
ZP3IZUMO1Q8IYV9754
ZP3NOBOXO60393743
ZP3FIGLAQ6QHK4734
ZP3DAZLQ92904660
ZP3BMP15O95972657
ZP3CACNA1GO43497642
ZP3ASTLQ6HA08632

IntAct

31 interactions, top by confidence:

ABTypeScore
ZP3ZP3psi-mi:“MI:0407”(direct interaction)0.600
ZP3VDAC2psi-mi:“MI:0915”(physical association)0.520
ZP3UBAP2Lpsi-mi:“MI:0915”(physical association)0.490
ZP3SPACA3psi-mi:“MI:0915”(physical association)0.490
ZP3PCDH17psi-mi:“MI:0915”(physical association)0.490
ZP3MICALL1psi-mi:“MI:0915”(physical association)0.490
ZP3ACRpsi-mi:“MI:0407”(direct interaction)0.440
ZP3ODF2psi-mi:“MI:0915”(physical association)0.400
ZP3TPI1psi-mi:“MI:0915”(physical association)0.400
ZP3GSTM3psi-mi:“MI:0915”(physical association)0.400
ZP3GAPDHSpsi-mi:“MI:0915”(physical association)0.400
ZP3GPX4psi-mi:“MI:0915”(physical association)0.400
ZP3PKMpsi-mi:“MI:0915”(physical association)0.400
ZP3ENO1psi-mi:“MI:0915”(physical association)0.400
ZP1ZP3psi-mi:“MI:0914”(association)0.350
ZP2ZP3psi-mi:“MI:0914”(association)0.350
ZP3ZP1psi-mi:“MI:0914”(association)0.350
ZP3SERPINB8psi-mi:“MI:0914”(association)0.350

BioGRID (16): ZP3 (Affinity Capture-RNA), ZP3 (Affinity Capture-RNA), ZP3 (Two-hybrid), ZP3 (Two-hybrid), FAM63A (Affinity Capture-MS), GET4 (Affinity Capture-MS), SERPINB8 (Affinity Capture-MS), ZP3 (Positive Genetic), ZP3 (Affinity Capture-RNA), UBAP2L (Two-hybrid), MRPS16 (Two-hybrid), SPACA3 (Two-hybrid), OR2L13 (Two-hybrid), PCDH17 (Two-hybrid), MICALL1 (Two-hybrid)

ESM2 similar proteins: G7PWZ3, I6M4H4, O08852, O54766, O77726, O95428, P08751, P10761, P17813, P20239, P21754, P23491, P35054, P37176, P42098, P42099, P43021, P47983, P47984, P48829, P48830, P48831, P48832, P48833, P48834, P53785, P53786, P60852, P79762, P97708, Q00193, Q05996, Q07104, Q07287, Q12836, Q3HRV3, Q3S2X5, Q5DID0, Q5DID3, Q62005

Diamond homologs: G5E8D7, P21754, P53785, Q925U0, P10761, P23491, P42098, P48830, P48831, P48832, P48833, P53786, P79762, P97708, Q6PJE2, Q60997, Q8CIZ5, Q95218, A8CG34, P52591, Q8K3Z9, Q96HA1, Q96KW2

SIGNOR signaling

1 interactions.

AEffectBMechanism
SOHLH1“up-regulates quantity by expression”ZP3“transcriptional regulation”

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 16 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

GO biological processes:

GO termPartnersFoldFDR
binding of sperm to zona pellucida5131.7×2e-08

Disease & clinical

Clinical variants and AI predictions

ClinVar

122 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic4
Likely pathogenic1
Uncertain significance78
Likely benign13
Benign10

Top pathogenic / likely-pathogenic (5)

Variant IDHGVSClassification
1285239NM_001110354.2(ZP3):c.499GAG[1] (p.Glu168del)Pathogenic
1711657NM_001110354.2(ZP3):c.831+1G>CPathogenic
437933NM_001110354.2(ZP3):c.400G>A (p.Ala134Thr)Pathogenic
689403NM_001110354.2(ZP3):c.763C>G (p.Arg255Gly)Pathogenic
1333775NM_001110354.2(ZP3):c.157dup (p.Val53fs)Likely pathogenic

SpliceAI

1836 predictions. Top by Δscore:

VariantEffectΔscore
7:76397833:C:CAacceptor_loss1.0000
7:76397834:T:Aacceptor_loss1.0000
7:76398714:A:ACdonor_gain1.0000
7:76398715:C:CCdonor_gain1.0000
7:76398715:CGT:Cdonor_gain1.0000
7:76398715:CGTA:Cdonor_gain1.0000
7:76398716:GTA:Gdonor_loss1.0000
7:76398717:TA:Tdonor_loss1.0000
7:76398718:A:ACdonor_gain1.0000
7:76398719:C:CTdonor_gain1.0000
7:76398719:CT:Cdonor_gain1.0000
7:76398719:CTT:Cdonor_gain1.0000
7:76398719:CTTT:Cdonor_gain1.0000
7:76398795:ATTC:Aacceptor_loss1.0000
7:76398796:TT:Tacceptor_gain1.0000
7:76398797:TCT:Tacceptor_loss1.0000
7:76398798:C:CCacceptor_gain1.0000
7:76398799:T:Cacceptor_loss1.0000
7:76409409:CATA:Cdonor_loss1.0000
7:76409410:ATAC:Adonor_loss1.0000
7:76409411:TA:Tdonor_loss1.0000
7:76409413:C:CGdonor_loss1.0000
7:76425273:GCAG:Gdonor_gain1.0000
7:76425274:CAGGT:Cdonor_loss1.0000
7:76425276:GGT:Gdonor_loss1.0000
7:76425277:G:GGdonor_gain1.0000
7:76425277:GT:Gdonor_loss1.0000
7:76425278:T:Adonor_loss1.0000
7:76429510:TCCA:Tacceptor_loss1.0000
7:76429512:CAGG:Cacceptor_loss1.0000

AlphaMissense

2790 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:76440312:G:CK298N0.997
7:76440312:G:TK298N0.997
7:76434076:T:GF251C0.996
7:76434039:T:AC239S0.995
7:76434040:G:CC239S0.995
7:76429620:T:AC140S0.994
7:76429621:G:CC140S0.994
7:76434112:T:CF263S0.994
7:76440263:G:AC282Y0.994
7:76440264:C:GC282W0.994
7:76440316:T:AC300S0.994
7:76440317:G:CC300S0.994
7:76433583:T:AC217S0.993
7:76433584:G:CC217S0.993
7:76440262:T:AC282S0.993
7:76440262:T:CC282R0.993
7:76440263:G:CC282S0.993
7:76440478:G:CW309C0.993
7:76440478:G:TW309C0.993
7:76434075:T:CF251L0.992
7:76434077:C:AF251L0.992
7:76434077:C:GF251L0.992
7:76434133:T:GF270C0.992
7:76440269:T:CL284P0.992
7:76433584:G:AC217Y0.991
7:76434039:T:CC239R0.991
7:76433585:C:GC217W0.990
7:76434076:T:CF251S0.989
7:76434126:T:CF268L0.989
7:76434128:C:AF268L0.989

dbSNP variants (sampled 300 via entrez): RS1000029426 (7:76414463 C>G), RS1000104374 (7:76427838 G>A), RS1000116853 (7:76414070 C>G,T), RS1000193036 (7:76420027 C>G), RS1000303488 (7:76425748 T>C), RS1000484199 (7:76414057 C>G,T), RS1000490195 (7:76430454 G>A), RS1000614217 (7:76433577 G>A), RS1000614248 (7:76397660 G>A), RS1000643648 (7:76433797 T>C,G), RS1000716146 (7:76429025 C>T), RS1000827265 (7:76409872 T>A), RS1000895507 (7:76414414 G>A,T), RS1001020356 (7:76436577 A>G,T), RS1001060809 (7:76401868 T>C)

Disease associations

OMIM: gene MIM:182889 | disease phenotypes: MIM:617712

GenCC curated gene-disease

DiseaseClassificationInheritance
oocyte maturation defect 3StrongAutosomal dominant
female infertility due to zona pellucida defectSupportiveAutosomal dominant
inherited oocyte maturation defectLimitedAutosomal recessive

Mondo (3): oocyte maturation defect 3 (MONDO:0021574), inherited oocyte maturation defect (MONDO:0014769), female infertility due to zona pellucida defect (MONDO:0014342)

Orphanet (0):

HPO phenotypes

3 total (3 of 3 shown, HPO-id order):

HPOTerm
HP:0000006Autosomal dominant inheritance
HP:0008222Female infertility
HP:0011462Young adult onset

GWAS associations

1 associations (top):

StudyTraitp-value
GCST002778_4Parkinson disease and lewy body pathology7.000000e-07

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

27 total (human), top 27 by PubMed support.

ChemicalActions (top 5)PubMed papers
Aflatoxin B1decreases methylation, increases expression3
Smokeincreases abundance, decreases expression2
Tretinoindecreases expression2
aristolochic acid Iincreases expression1
ethyl-p-hydroxybenzoatedecreases expression1
sulforaphaneincreases expression1
tris(1,3-dichloro-2-propyl)phosphateincreases expression1
S-(1,2-dichlorovinyl)cysteineaffects cotreatment, increases expression1
ICG 001increases expression1
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amideaffects cotreatment, increases expression1
jinfukangincreases expression1
Temozolomideincreases expression1
Acetaminophendecreases expression1
Air Pollutantsdecreases expression, increases abundance1
Arsenicaffects methylation1
Azacitidineincreases expression1
Benzo(a)pyreneaffects methylation1
Hydrogen Peroxideaffects expression1
Lipopolysaccharidesaffects cotreatment, increases expression1
Mustard Gasincreases expression1
Ozoneincreases expression1
Rotenoneincreases expression1
Tetrachlorodibenzodioxinaffects cotreatment, increases expression1
Tobacco Smoke Pollutionincreases expression1
Triclosanincreases expression1
Valproic Acidincreases methylation1
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideincreases expression1

Cellosaurus cell lines

1 cell lines: 1 spontaneously immortalized cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_K172HuZP3-CHOLec3.2.8.1Spontaneously immortalized cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.